Krüppel-like factor 5 transcription factor promotes microsomal prostaglandin E2 synthase 1 gene transcription in breast cancer

Journal of Biological Chemistry

Volumn 288, Issue 37, 2013, Pages 26731-26740

  Xia, Houjun ^a   Wang, Chunyan ^a,b,c   Chen, Wenlin ^c   Zhang, Hailin ^a   Chaudhury, Leena ^d   Zhou, Zhongmei ^a   Liu, Rong ^a   Chen, Ceshi ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

^d ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; FUNCTIONAL MECHANISMS; GENE TRANSCRIPTIONS; MICROSOMAL PROSTAGLANDIN; MPGES-1; REGULATION MECHANISMS; SYNTHASES; TRANSCRIPTIONAL TARGETS;

CELL PROLIFERATION; DISEASES; GENES; TRANSCRIPTION FACTORS;

TRANSCRIPTION;

KRUPPEL LIKE FACTOR 5; MESSENGER RNA; PROSTAGLANDIN E SYNTHASE 1; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; ISOMERASE; KLF5 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; PHORBOL ESTER; PROSTAGLANDIN E SYNTHASE; TUMOR MARKER; BIOLOGICAL MARKER; PROSTAGLANDIN E2;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EXON; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; GROWTH INHIBITION; MPGES1 GENE; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; BREAST TUMOR; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; MCF 7 CELL LINE; METABOLISM; MICROSOME; TUMOR CELL LINE; CELL STRAIN MCF 7; KLF5; MPGES1; PROLIFERATION; TRANSCRIPTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; INTRAMOLECULAR OXIDOREDUCTASES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MCF-7 CELLS; MICROSOMES; PHORBOL ESTERS; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

BIOMARKERS; BREAST CANCER; KLF5; MPGES1; PGE2; PHORBOL ESTERS; PROLIFERATION; TRANSCRIPTION;

EID: 84884198578     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.483958     Document Type: Article

References (56)

1. Dong, J. T., and Chen, C. (2009) Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell. Mol. Life Sci. 66, 2691-2706
2. Liu, R., Zhou, Z., Zhao, D., and Chen, C. (2011) The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. Mol. Endocrinol. 25, 1137-1144
3. Zheng, H. Q., Zhou, Z., Huang, J., Chaudhury, L., Dong, J. T., and Chen, C. (2009) Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1. Oncogene 28, 3702-3713
4. Liu, R., Zheng, H. Q., Zhou, Z., Dong, J. T., and Chen, C. (2009) KLF5 promotes breast cell survival partially through fibroblast growth factorbinding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization. J. Biol. Chem. 284, 16791-16798
5. Bateman, N. W., Tan, D., Pestell, R. G., Black, J. D., and Black, A. R. (2004) Intestinal tumor progression is associated with altered function of KLF5. J. Biol. Chem. 279, 12093-12101
6. He, M., Han, M., Zheng, B., Shu, Y. N., and Wen, J. K. (2009) Angiotensin II stimulates KLF5 phosphorylation and its interaction with c-Jun leading to suppression of p21 expression in vascular smooth muscle cells. J. Biochem. 146, 683-691
7. Zhu, N., Gu, L., Findley, H. W., Chen, C., Dong, J. T., Yang, L., and Zhou, M. (2006) KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia. J. Biol. Chem. 281, 14711-14718
8. Chen, C., Benjamin, M. S., Sun, X., Otto, K. B., Guo, P., Dong, X. Y., Bao, Y., Zhou, Z., Cheng, X., Simons, J. W., and Dong, J. T. (2006) KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line. Int. J. Cancer 118, 1346-1355
9. Nakanishi, M., Gokhale, V., Meuillet, E. J., and Rosenberg, D. W. (2010) mPGES-1 as a target for cancer suppression: a comprehensive invited review "Phospholipase A2 and lipid mediators." Biochimie 92, 660-664
10. Naraba, H., Yokoyama, C., Tago, N., Murakami, M., Kudo, I., Fueki, M., Oh-Ishi, S., and Tanabe, T. (2002) Transcriptional regulation of the membrane- associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1. J. Biol. Chem. 277, 28601-28608
11. Wang, D., and Dubois, R. N. (2010) Eicosanoids and cancer. Nat. Rev. Cancer 10, 181-193
12. Chandrasekharan, S., Foley, N. A., Jania, L., Clark, P., Audoly, L. P., and Koller, B. H. (2005) Coupling of COX-1 to mPGES1 for prostaglandin E2 biosynthesis in the murine mammary gland. J. Lipid Res. 46, 2636-2648
13. Mehrotra, S., Morimiya, A., Agarwal, B., Konger, R., and Badve, S. (2006) Microsomal prostaglandin E2 synthase-1 in breast cancer: a potential target for therapy. J. Pathol. 208, 356-363
14. Hanaka, H., Pawelzik, S. C., Johnsen, J. I., Rakonjac, M., Terawaki, K., Rasmuson, A., Sveinbjörnsson, B., Schumacher, M. C., Hamberg, M., Samuelsson, B., Jakobsson, P. J., Kogner, P., and Radmark, O. (2009) Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells. Proc. Natl. Acad. Sci. U.S.A. 106, 18757-18762
15. Nakanishi, M., Montrose, D. C., Clark, P., Nambiar, P. R., Belinsky, G. S., Claffey, K. P., Xu, D., and Rosenberg, D. W. (2008) Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. Cancer Res. 68, 3251-3259
16. Forsberg, L., Leeb, L., Thorén, S., Morgenstern, R., and Jakobsson, P. (2000) Human glutathione dependent prostaglandin E synthase: gene structure and regulation. FEBS lett. 471, 78-82
17. Stichtenoth, D. O., Thorén, S., Bian, H., Peters-Golden, M., Jakobsson, P. J., and Crofford, L. J. (2001) Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells. J. Immunol. 167, 469-474
18. Catley, M. C., Chivers, J. E., Cambridge, L. M., Holden, N., Slater, D. M., Staples, K. J., Bergmann, M. W., Loser, P., Barnes, P. J., and Newton, R. (2003) IL-1β-dependent activation of NF-κB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase. FEBS Lett. 547, 75-79
19. Walters, J. N., Bickford, J. S., Newsom, K. J., Beachy, D. E., Barilovits, S. J., Herlihy, J. D., and Nick, H. S. (2012) Regulation of human microsomal prostaglandin E synthase-1 by IL-1βrequires a distal enhancer element with a unique role for C/EBPβ. Biochem. J. 443, 561-571
20. Díaz-Muñoz, M. D., Osma-García, I. C., Fresno, M., and Iñiguez, M. A. (2012) Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages. Biochem. J. 443, 451-461
21. Ekström, L., Lyrenäs, L., Jakobsson, P. J., Morgenstern, R., and Kelner, M. J. (2003) Basal expression of the human MAPEG members microsomal glutathione transferase 1 and prostaglandin E synthase genes is mediated by Sp1 and Sp3. Biochim. Biophys. Acta 1627, 79-84
22. Donnini, S., Finetti, F., Terzuoli, E., Giachetti, A., Iñiguez, M. A., Hanaka, H., Fresno, M., Radmark, O., and Ziche, M. (2012) EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity. Oncogene 31, 3457-3466
23. Deckmann, K., Rörsch, F., Steri, R., Schubert-Zsilavecz, M., Geisslinger, G., and Grösch, S. (2010) Dimethylcelecoxib inhibits mPGES-1 promoter activity by influencing EGR1 and NF-κB. Biochem. Pharmacol. 80, 1365-1372
24. Chen, C., Sun, X., Ran, Q., Wilkinson, K. D., Murphy, T. J., Simons, J. W., and Dong, J. T. (2005) Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene 24, 3319-3327
25. Chen, C., Bhalala, H. V., Vessella, R. L., and Dong, J. T. (2003) KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate 55, 81-88
26. Wang, X., and Zhao, J. (2007) KLF8 transcription factor participates in oncogenic transformation. Oncogene 26, 456-461
27. Chen, C., Zhou, Z., Ross, J. S., Zhou, W., and Dong, J. T. (2007) The amplified WWP1 gene is a potential molecular target in breast cancer. Int. J. Cancer 121, 80-87
28. Park, S. Y., Kim, Y. H., Kim, Y., and Lee, S. J. (2012) Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells. J. Cell. Biochem. 113, 3653-3662
29. Lu, D., Han, C., and Wu, T. (2012) Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/- catenin signaling axis. Oncogene 31, 842-857
30. Zhang, H., Bialkowska, A., Rusovici, R., Chanchevalap, S., Shim, H., Katz, J. P., Yang, V. W., and Yun, C. C. (2007) Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Krüppel-like factor, J. Biol. Chem. 282, 15541-15549
31. Deng, N., Goh, L. K., Wang, H., Das, K., Tao, J., Tan, I. B., Zhang, S., Lee, M., Wu, J., Lim, K. H., Lei, Z., Goh, G., Lim, Q. Y., Tan, A. L., Sin Poh, D. Y., Riahi, S., Bell, S., Shi, M. M., Linnartz, R., Zhu, F., Yeoh, K. G., Toh, H. C., Yong, W. P., Cheong, H. C., Rha, S. Y., Boussioutas, A., Grabsch, H., Rozen, S., and Tan, P. (2012) A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut 61, 673-684
32. Goldstein, B. G., Chao, H. H., Yang, Y., Yermolina, Y. A., Tobias, J. W., and Katz, J. P. (2007) Overexpression of Krüppel-like factor 5 in esophageal epithelia in vivo leads to increased proliferation in basal but not suprabasal cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G1784-G1792
33. Tong, D., Czerwenka, K., Heinze, G., Ryffel, M., Schuster, E., Witt, A., Leodolter, S., and Zeillinger, R. (2006) Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Clin. Cancer Res. 12, 2442-2448
34. Takagi, K., Miki, Y., Onodera, Y., Nakamura, Y., Ishida, T., Watanabe, M., Inoue, S., Sasano, H., and Suzuki, T. (2012) Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens. Endocr. Relat. Cancer 19, 741-750
35. Zhao, D., Zhi, X., Zhou, Z., and Chen, C. (2012) TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis. Carcinogenesis 33, 59-67
36. Kamei, D., Murakami, M., Nakatani, Y., Ishikawa, Y., Ishii, T., and Kudo, I. (2003) Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis. J. Biol. Chem. 278, 19396-19405
37. Shindo, T., Manabe, I., Fukushima, Y., Tobe, K., Aizawa, K., Miyamoto, S., Kawai-Kowase, K., Moriyama, N., Imai, Y., Kawakami, H., Nishimatsu, H., Ishikawa, T., Suzuki, T., Morita, H., Maemura, K., Sata, M., Hirata, Y., Komukai, M., Kagechika, H., Kadowaki, T., Kurabayashi, M., and Nagai, R. (2002) Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat. Med. 8, 856-863
38. Chanchevalap, S., Nandan, M. O., McConnell, B. B., Charrier, L., Merlin, D., Katz, J. P., and Yang, V. W. (2006) Krüppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells. Nucleic Acids Res. 34, 1216-1223
39. Bafford, R., Sui, X. X., Wang, G., and Conte, M. (2006) Angiotensin II and tumor necrosis factor-βupregulate survivin and Krüppel-like factor 5 in smooth muscle cells: potential relevance to vein graft hyperplasia. Surgery 140, 289-296
40. Sur, I., Undén, A. B., and Toftgard, R. (2002) Human Krüppel-like factor 5/KLF5: synergy with NF-κB/Rel factors and expression in human skin and hair follicles. Eur. J. Cell Biol. 81, 323-334
41. Silva, E., Leitao, S., Henriques, S., Kowalewski, M. P., Hoffmann, B., Ferreira- Dias, G., da Costa, L. L., and Mateus, L. (2010) Gene transcription of TLR2, TLR4, LPS ligands and prostaglandin synthesis enzymes are upregulated in canine uteri with cystic endometrial hyperplasia-pyometra complex. J. Reprod. Immunol. 84, 66-74
42. Nandan, M. O., Yoon, H. S., Zhao, W., Ouko, L. A., Chanchevalap, S., and Yang, V. W. (2004) Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras. Oncogene 23, 3404-3413
43. Kawai-Kowase, K., Kurabayashi, M., Hoshino, Y., Ohyama, Y., and Nagai, R. (1999) Transcriptional activation of the zinc finger transcription factor BTEB2 gene by Egr-1 through mitogen-activated protein kinase pathways in vascular smooth muscle cells. Circ. Res. 85, 787-795
44. Oishi, Y., Manabe, I., Tobe, K., Tsushima, K., Shindo, T., Fujiu, K., Nishimura, G., Maemura, K., Yamauchi, T., Kubota, N., Suzuki, R., Kitamura, T., Akira, S., Kadowaki, T., and Nagai, R. (2005) Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab. 1, 27-39
45. Samuelsson, B., Morgenstern, R., and Jakobsson, P. J. (2007) Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol. Rev. 59, 207-224
46. Murakami, M., Naraba, H., Tanioka, T., Semmyo, N., Nakatani, Y., Kojima, F., Ikeda, T., Fueki, M., Ueno, A., Oh, S., and Kudo, I. (2000) Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275, 32783-32792
47. Kim, H. S., Moon, H. G., Han, W., Yom, C. K., Kim, W. H., Kim, J. H., and Noh, D. Y. (2012) COX2 overexpression is a prognostic marker for Stage III breast cancer. Breast Cancer Res. Treat. 132, 51-59
48. Chang, S. H., Ai, Y., Breyer, R. M., Lane, T. F., and Hla, T. (2005) The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia. Cancer Res. 65, 4496-4499
49. Harris, R. E., Alshafie, G. A., Abou-Issa, H., and Seibert, K. (2000) Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res. 60, 2101-2103
50. Kubatka, P., Ahlers, I., Ahlersová, E., Adámeková, E., Luk, P., Bojková, B., and Marková, M. (2003) Chemoprevention of mammary carcinogenesis in female rats by rofecoxib. Cancer Lett. 202, 131-136
51. Uematsu, S., Matsumoto, M., Takeda, K., and Akira, S. (2002) Lipopolysaccharide- dependent prostaglandin E2 production is regulated by the glutathione-dependent prostaglandin E2 synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J. Immunol. 168, 5811-5816
52. Guerrero, M. D., Aquino, M., Bruno, I., Riccio, R., Terencio, M. C., and Payá, M. (2009) Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression. Eur. J. Pharmacol. 620, 112-119
53. Koeberle, A., Rossi, A., Zettl, H., Pergola, C., Dehm, F., Bauer, J., Greiner, C., Reckel, S., Hoernig, C., Northoff, H., Bernhard, F., Dötsch, V., Sautebin, L., Schubert-Zsilavecz, M., and Werz, O. (2010) The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino) pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase. J. Pharmacol. Exp. Ther. 332, 840-848
54. Rörsch, F., Wobst, I., Zettl, H., Schubert-Zsilavecz, M., Grösch, S., Geisslinger, G., Schneider, G., and Proschak, E. (2010) Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES1) identified by a multistep virtual screening protocol. J. Med. Chem. 53, 911-915
55. Chen, C. J., Lin, S. E., Lin, Y. M., Lin, S. H., Chen, D. R., and Chen, C. L. (2012) Association of expression of Krüppel-like factor 4 and Krüppel-like factor 5 with the clinical manifestations of breast cancer. Pathol. Oncol. Res. 18, 161-168
56. Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C., Schreiber, S. L., Mellor, J., and Kouzarides, T. (2002) Active genes are tri-methylated at K4 of histone H3. Nature 419, 407-411